No. 16-332

Apotex Inc., et al. v. Amgen Inc., et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

Reply of petitioners Apotex Inc., et al. filed. (Distributed)

DISTRIBUTED for Conference of December 9, 2016.

Letter of November 17, 2016, from counsel for petitioners received waiving the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5.

Brief of respondents Amgen Inc., et al. in opposition filed.

Brief amicus curiae of Mylan Pharmaceuticals Inc. filed.

Brief amicus curiae of The Biosimilars Council filed.

Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the petitioners,

Order extending time to file response to petition to and including November 8, 2016.

Petition for a writ of certiorari filed. (Response due October 14, 2016)


Apotex Inc., et al., Petitioner, represented by David C. Frederick

Amgen Inc., et al., Respondent, represented by Nicholas Groombridge

Amici Curiae

Mylan Pharmaceuticals Inc., Amicus Curiae, represented by William A. Rakoczy

The Biosimilars Council, Amicus Curiae, represented by William M. Jay

Last updated: April 18, 2017